865838-13-7

Basic information

• Product Name: 4H-Cyclopenta-1,3-dioxol-4-ol, 3a,6a-dihydro-2,2-diMethyl-4-[(triphenylMethoxy)Methyl]-, (3aS,4R,6aS)-
• Synonyms: 4H-Cyclopenta-1,3-dioxol-4-ol, 3a,6a-dihydro-2,2-diMethyl-4-[(triphenylMethoxy)Methyl]-, (3aS,4R,6aS)-;(3aS,4R,6aS)-2,2-Dimethyl-4-((Trityloxy)Methyl)-4,6a-Dihydro-3aH-Cyclopenta[D][1,3]Dioxol-4-Ol
• CAS NO: 865838-13-7
• Molecular Formula: C₂₈H₂₈O₄
• Molecular Weight: 428.51952
• Mol File: 865838-13-7.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4H-Cyclopenta-1,3-dioxol-4-ol, 3a,6a-dihydro-2,2-diMethyl-4-[(triphenylMethoxy)Methyl]-, (3aS,4R,6aS)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-Cyclopenta-1,3-dioxol-4-ol, 3a,6a-dihydro-2,2-diMethyl-4-[(triphenylMethoxy)Methyl]-, (3aS,4R,6aS)-(865838-13-7)
• EPA Substance Registry System: 4H-Cyclopenta-1,3-dioxol-4-ol, 3a,6a-dihydro-2,2-diMethyl-4-[(triphenylMethoxy)Methyl]-, (3aS,4R,6aS)-(865838-13-7)

Safety Data

• Hazardous Substances Data: 865838-13-7(Hazardous Substances Data)

Upstream product

• 902799-71-7 C₃₀H₃₂O₄ 
• 532-20-7 D-Ribose 
• 67814-68-0 2,3-O-isopropylidene-D-ribofuranose 
• 681853-96-3 (-)-1-[(4S,5S)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-yl]-2-(triphenylmethyloxy)ethan-1-one 
• 95666-80-1 (1R)-(-)-1-[(4R,5S)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-yl]-2-(triphenylmethyloxy)ethan-1-ol 
• 1779-49-3 Methyltriphenylphosphonium bromide 
• 54503-64-9 2,3-O-isopropylidene-5-O-trityl-D-ribofuranose 
• 865838-12-6 (1R)-(-)-1-[(4S,5S)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-yl]-1-(triphenylmethyloxymethyl)-2-propen-1-ol 

Downstream Products

• 805245-40-3 tert-butyl(((3aR,4R,6aR)-5-iodo-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)diphenylsilane 
• 805245-41-4 tert-butyl(((3aR,4R,6aR)-5-fluoro-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)diphenylsilane 
• 805245-39-0 (3aS,4R,6aR)-5-iodo-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol 
• 805245-42-5 (3aS,4R,6aR)-5-fluoro-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol 
• 805245-38-9 (3aR,6aR)-5-iodo-2,2-dimethyl-6-((trityloxy)methyl)-3aH-cyclopenta[d][1,3]dioxol-4(6aH)-one 
• 865838-14-8 (3R,4S,6aR)-3-benzoyl-1-(5-fluoro-2,2-dimethyl-6-trityloxymethyl-4,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-yl)-1H-pyrimidine-2,4-dione 
• 1373332-60-5 C₂₉H₄₁FN₂O₇SSi₂ 
• 865838-26-2 RX-3117 
• 88559-56-2 (3aR,6aR)-2,2-dimethyl-6-[(trityloxy)methyl]-3a,6a-dihydro-4H-cyclopenta[d][1,3]dioxol-4-one 

Relevant articles and documents

Tumor immunity compound and application thereof

Disclosed are a tumor immunity compound and an application thereof. The invention discloses a compound as shown in the formula (I), optical isomers thereof, and pharmaceutically acceptable salts thereof, and an application of the compound as an STING agonist.

Nucleoside derivatives and therapeutic uses therof

The present invention relates to nucleoside derivatives represented by general formulas I and II, their synthetic methods and their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperprolifera